QC
BNTX icon

Quadrature Capital’s BioNTech BNTX Stock Holding History

Quadrature Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32M Buy
+67,965
New +$6.4M 0.05% 247
2026
Q1 		– Sell
-160,464
Closed -$15.3M – 1408
2025
Q4 		$15.3M Buy
160,464
+138,261
+623% +$13.9M 0.16% 119
2025
Q3 		$2.19M Buy
+22,203
New +$2.37M 0.03% 278

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Quadrature Capital's BNTX Position: Q2 2026 in Review

Quadrature Capital opened a new position in BioNTech (BNTX) in Q2 2026: 67,965 shares worth $6.32M. The stake represents 0.05% of the portfolio and ranks #247 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in BNTX as recently as Q4 2025.

Quadrature Capital first reported a position in BNTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.3M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Quadrature Capital held 67,965 shares of BioNTech worth $6.32M as of Q2 2026.
  • BioNTech was a new Quadrature Capital position in Q2 2026.
  • BioNTech made up 0.05% of Quadrature Capital's portfolio in Q2 2026, its #247 holding.
  • Quadrature Capital first reported a position in BioNTech in Q3 2025 and has held it in 3 quarters since.
  • Quadrature Capital's BioNTech position peaked at $15.3M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.